Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.
Saved in:
| Title: | Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. |
|---|---|
| Authors: | Horeweg N; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands. n.horeweg@lumc.nl., Workel HH; Department of Gynaecologic Oncology, University Medical Center Groningen, Groningen, the Netherlands., Loiero D; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Church DN; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Vermij L; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Léon-Castillo A; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Krog RT; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Department Surgery, Leiden University Medical Center, Leiden, the Netherlands., de Boer SM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Nout RA; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Powell ME; Department of Clinical Oncology, Barts Health NHS Trust, London, United Kingdom., Mileshkin LR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., MacKay H; Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada., Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Singh N; Department of Pathology, Barts Health NHS Trust, London, United Kingdom., Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Oncology and Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Nijman HW; Department of Gynaecologic Oncology, University Medical Center Groningen, Groningen, the Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., de Bruyn M; Department of Gynaecologic Oncology, University Medical Center Groningen, Groningen, the Netherlands. |
| Corporate Authors: | TransPORTEC consortium |
| Source: | Nature communications [Nat Commun] 2022 Mar 16; Vol. 13 (1), pp. 1373. Date of Electronic Publication: 2022 Mar 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-022-29040-x |
